Myonit SR 2.6 Tablet
By Myonit
Rx
30 Tablet CR in a Bottle

Composition
Nitroglycerin(2.6mg)

Manufacturer - Troikaa Pharmaceuticals Ltd
Troikaa Pharmaceuticals Ltd., Registered Office: , 'Commerce House - 1', Satya Marg, Bodakdev, Ahmedabad-380 054. Gujarat, India.

Expires on or after
July, 2026

liver
Limited information is available regarding the use of Myonit SR 2.6 Tablet in patients with liver disease. It is important to consult your doctor before using this medication if you have any liver issues. Your doctor will be able to provide you with the necessary guidance and determine if it is safe for you to take Myonit SR 2.6 Tablet based on your liver condition. Taking precautions and seeking medical advice will help ensure your safety and well-being while using this medication.

kidney
Limited data suggests Myonit SR 2.6 Tablet is likely safe for patients with kidney disease. Consult your doctor for guidance, as dose adjustment may not be necessary.

alcohol
When taking Myonit SR 2.6 Tablet, avoid consuming alcohol to prevent symptoms like flushing, increased heart rate, nausea, thirst, chest pain, and low blood pressure.

driving
Caution while driving Myonit SR 2.6 Tablet may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Myonit SR 2.6 Tablet is believed to be safe in pregnancy based on limited human studies. Animal studies showed minimal effects.

breastfeeding
Based on limited human data, Myonit SR 2.6 Tablet is considered safe while breastfeeding, with no significant risks to the baby identified.
Habit Forming | No |
Chemical Class | Nitrates |
Therapeutic Class | - |
Action Class | NO Donors |
₹309.76
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024